Last $44.20 USD
Change Today +0.36 / 0.82%
Volume 1.5M
ZTS On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

zoetis inc (ZTS) Snapshot

Open
$43.80
Previous Close
$43.84
Day High
$44.29
Day Low
$43.80
52 Week High
12/1/14 - $45.24
52 Week Low
04/15/14 - $28.14
Market Cap
22.2B
Average Volume 10 Days
4.2M
EPS TTM
$1.46
Shares Outstanding
501.3M
EX-Date
01/20/15
P/E TM
30.2x
Dividend
$0.33
Dividend Yield
0.65%
Current Stock Chart for ZOETIS INC (ZTS)

zoetis inc (ZTS) Details

Zoetis Inc. is engaged in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals worldwide. It operates through four segments: United States, Europe/Africa/Middle East, Canada/Latin America, and Asia/Pacific. The company offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines that are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms. It also provides medicated feed additives that offer medicines to livestock; and other pharmaceutical products, including pain and sedation, oncology, antiemetic, allergy, and dermatology products, as well as reproductive products. The company markets its products to veterinarians and livestock producers through its sales representatives, and technical and veterinary operations specialists. Zoetis Inc. was founded in 1952 and is headquartered in Florham Park, New Jersey.

9,800 Employees
Last Reported Date: 03/26/14
Founded in 1952

zoetis inc (ZTS) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $825.0K
Group President and Executive Vice President
Total Annual Compensation: $605.0K
Executive Vice President and President of U.S...
Total Annual Compensation: $400.0K
President of Research & Development and Execu...
Total Annual Compensation: $400.0K
Compensation as of Fiscal Year 2013.

zoetis inc (ZTS) Key Developments

Zoetis Inc.(NYSE:ZTS) dropped from S&P 500 Value Index

Zoetis Inc.(NYSE:ZTS) dropped from S&P 500 Value Index

Zoetis Inc. Declares Dividend on Common Stock for the First Quarter of 2015, Payable on March 3, 2015

The board of directors of Zoetis Inc. has declared a first quarter 2015 dividend payable to holders of the company's common stock of $0.083 per share, an increase of 15% from the quarterly dividend rate paid in 2014. The dividend is to be paid on Mar. 3, 2015, to holders of record on Jan. 22, 2015.

Zoetis Inc. Presents at Bank of America Merrill Lynch 2014 Animal Health Summit, Dec-11-2014 12:30 PM

Zoetis Inc. Presents at Bank of America Merrill Lynch 2014 Animal Health Summit, Dec-11-2014 12:30 PM. Venue: Bank of America Conference Center, Boston, Massachusetts, United States. Speakers: Clinton A. Lewis, Executive Vice President and President of U.S. Operations, Paul S. Herendeen, Chief Financial Officer and Executive Vice President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZTS:US $44.20 USD +0.36

ZTS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ImmuCell Corp $4.82 USD -0.18
Parnell Pharmaceuticals Holdings Ltd $4.47 USD -0.41
Phibro Animal Health Corp $30.70 USD +2.00
Valneva SE €4.15 EUR -0.05
Virbac SA €174.15 EUR +0.65
View Industry Companies
 

Industry Analysis

ZTS

Industry Average

Valuation ZTS Industry Range
Price/Earnings 39.4x
Price/Sales 4.7x
Price/Book 16.2x
Price/Cash Flow 35.6x
TEV/Sales 3.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZOETIS INC, please visit www.zoetis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.